Clinical Trials List
Protocol NumberD8750C00014
Not yet recruiting
2026-08-01 - 2029-12-31
Phase III
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 陳怡文 Division of Endocrinology
- Chih-Yiu Tsai Division of Endocrinology
- 王涵芸 Division of Endocrinology
- 林怡瑄 Division of Endocrinology
- 林承緯 Division of Endocrinology
Co-Principal Investigator
- 朱志生 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
Co-Principal Investigator
- 賴瑩純 Division of Endocrinology
- 嚴愛文 Division of Endocrinology
- 粘峯榕 Division of Endocrinology
- 林家宏 Division of Endocrinology
- Tieng-Chun Chang Division of Endocrinology
Principal Investigator
周莒光
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
160 participants
-
Global
2500 participants